Among the most frequently observed mutations in newly diagnosed adult AML are NPM1 (≈30%), DNMT3A (≈20%), and FLT3 (≈20–25%) [3,4,10,11]. The gene discussed is FLT3; the disease is acute myeloid leukemia.